## Why Smart Investors Ignore Market Cap and Use Enterprise Value Instead
When evaluating whether a company is truly expensive or cheap, most retail investors make a critical mistake: they only look at market capitalization. They miss the full picture. Enterprise value (EV) is the metric that reveals what you're *actually* paying for a business, just like knowing the true cost of that used car after accounting for the cash you found in the trunk.
Think of it this way: if you acquire a company with $10 billion market cap but it carries $5 billion in debt you must assume, plus $1 billion in cash

## How a 19-Year-Old Built a $150 Million Fortune Through Crypto Ventures: The Barron Trump Story
When discussing the Trump family's financial empire, most attention focuses on President Donald Trump's $6 billion net worth accumulated through real estate, entertainment, and his merger with Trump Media & Technology Group. Yet his youngest son, Barron Trump, has quietly constructed a substantial personal wealth portfolio estimated at $150 million—largely through the emerging cryptocurrency sector. The question isn't just how, but what this reveals about wealth-building opportunities in digital a

Protalix BioTherapeutics Stock Gains on Secarna Partnership for Rare Kidney Disease Treatments
Biotech collaboration moves forward with AI-powered therapy development
Protalix BioTherapeutics, Inc. (PLX) shares climbed 2.78% to $1.85 in pre-market trading Wednesday, following the disclosure of a strategic partnership with Secarna Pharmaceuticals, a German biopharmaceutical innovator. The two companies have joined forces to create advanced antisense oligonucleotide (ASO) therapies targeting rare kidney conditions.
**The Strategic Alliance & Technology Focus**
Under the agreement structure, Prot